期刊文献+

深圳市同性恋门诊梅毒干预项目的成本-效果分析 被引量:3

Analysis on the Cost-Effectiveness of Syphilis Intervention Project for Homosexuals in Clinics of Shenzhen
原文传递
导出
摘要 目的:对2011年深圳市同性恋梅毒干预项目进行卫生经济学评价。方法:建立决策树模型并对项目进行成本效果分析和灵敏度分析。模型参数值来源于项目门诊记录、成本调查和文献回顾等。结果:2011年,首次就诊的男男性行为者为730人,梅毒检测阳性率为14.2%。项目每多发现并治疗1例梅毒病例、每避免1例梅毒传播、每避免1例三期梅毒和每挽救1个DALY所增加的成本分别为3 431元、503元、11 469元和850元。结论:该项目具有良好的成本效果,建议政府加大投入以扩大规模或在条件相似地区推广。 Objective: To perform health economic evaluation on syphilis intervention programme for homosexuals in Shenzhen. Methods: Decision tree model was established to implemenl a cost-effectiveness analysis and sensihvity on the program. Values of model parameters wen derived from project outpatient record, cost investigations and literature reviews. Results: In 2011, 730 men having sex with men (MSM) first visited the clinic and 14.3% were syphilis positive. Incremental cost pre incremental syphilis case detected and treated, per case averted from transmission, pre tertiary syphilis cases averted and pre DALY averted were 3 431, 503, 11 469 and 850yuan. Conclusion: The project has good cost-effective. The government is suggested to invest more to expand the scale or popularize in similar areas.
出处 《中国卫生经济》 北大核心 2013年第12期90-92,共3页 Chinese Health Economics
基金 国家“十二五”科技重大专项(2008ZX10001-005)
关键词 深圳市 梅毒 男男性行为者 成本-效果分析 Shenzhen syphilis men having sex with men cost and effectiveness analysis
  • 相关文献

参考文献22

  • 1WHO. Prevention and Treatment of HIV and Other Sexually Transmitted Infections among Men Who Have Sex with Men and Transgender People: Recommendations for A Public Health Approach[R]. Geneva: WHO, 2011.
  • 2邱英鹏,刘爱忠,冯铁建.中国大陆MSM人群HlV/梅毒感染情况、性行为特征和艾滋病知识知晓情况的Meta分析[J].2013,19(3):169-173.
  • 3Wang S, Moss J R, Hiller J E. The cost-effectiveness of HIV voluntary counseling and testing in China[J]. Asia Pac J Public Health, 2011,23(4) :620-633.
  • 4黄喜明,凌莉,周华,洪福昌,潘鹏.深圳市预防与控制梅毒母婴传播项目成本效果分析[J].华南预防医学,2009,35(3):5-8. 被引量:3
  • 5Drummond M F. Methods tbr the Economic Evalution of Health Care Programmes[M]. Third edition. New York: Oxford University Press, 2005.
  • 6Hutubessy R, Chisholm D, Edejer T T. Generalized cost- effectiveness analysis for national-leveE priority-setting in the health sector[J]. Cost Eft Resour Alloc, 2003,1 ( 1 ) : 8.
  • 7深圳市统计局.2012深圳统计年鉴[M].北京:中国统计出版社.2012.
  • 8Gerbase A. Global burden of Sexually Transmitted Diseases (excluding HIV)in the year 2000[R]. Geneva: WHO. 2001.
  • 9王毅,张洪波,李志军,徐杰,张光贵,斗智,杨宏武,樊静.MSM人群艾滋病性病防治行为干预效果评价[J].实用预防医学,2009,16(3):654-657. 被引量:36
  • 10王毅,张洪波,张光贵,杨宏武,樊静.绵阳市男男性行为人群艾滋病性病健康教育及行为干预效果研究[J].预防医学情报杂志,2008,24(12):962-967. 被引量:23

二级参考文献63

共引文献130

同被引文献22

  • 1杨文林,杨健,黄新宇,张红娟,林立,陈思华.梅毒血清固定病人的脑脊液及免疫功能检测[J].中国医师杂志,2005,7(5):644-646. 被引量:13
  • 2边旭明,董悦.早产的临床诊断与治疗推荐指南(草案)[J].中华妇产科杂志,2007,42(7):498-500. 被引量:125
  • 3Workowski Kimberly ABSM. Sexually Transmitted Diseases Treat- ment Guidelines. 2006.
  • 4Hook ER,Behets F,Damme KV,et al. A Phase III Equivalence Trial of Azithromycin versus Benzathine Penicillin for Treatment of Early Syphilis. Journal of Infectious Diseases ,2010,201 ( 11 ) : 1729-1735.
  • 5Dowell ME, Ross PG, Musher DM, et al. Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with hu- man immunodeficiency virus. American Journal of Medicine, 1992, 93(5) :481-488.
  • 6Maclean S, Luger A. Finding neurosyphilis without the Venereal Dis- ease Research Laboratorytest. Sex Transm Dis, 1996,23 ( 5 ) : 392- 394.
  • 7Dk O, Rf N, RH. Use of cost-effectiveness and value of information analyses to customize guidelines for specific clinical practice settings. Med Decis Making, 1993 (13) :395.
  • 8Soorapanth S, Sansom S,Bulterys M, et al. Cost-effectiveness of HIV rescreening during late pregnancy to prevent mother-to-child HIV transmission in South Africa and other resource-limited settings. JAIDS ,2006,42(2) :213-221.
  • 9Pahiel AD, Weinstein MC, Kimmel AD, et al. Expanded screening for HIV in the United States an analysis of cost-effectiveness. New England Journal of Medicine ,2005,352 ( 6 ) :586-595.
  • 10Sanders GD, Bayoumi AM, Sundaram V, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. New England Journal of Medicine,2005,352(6) :570-585.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部